Social determinants and hepatitis C among people who inject drugs in Kermanshah, Iran: Socioeconomic status, homelessness, and sufficient syringe coverage

References

• Alipour, A., Haghdoost, A. A., Sajadi, L., & Zolala F. (2010). HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: Results of a bio-behavioural survey. Sexually Transmitted Infections, 89(Suppl 3), iii41–iii44.
   Web of Science ®Google Scholar
• Bruneau, J., Lamothe, F., Franco, E., Lachance, N., Désy, M., Soto, J., et al. (1997). High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology, 146(12), 994–1002.
   PubMed Web of Science ®Google Scholar
• Coates, T. J., Richter, L., & Caceres, C. (2008). Behavioural strategies to reduce HIV transmission: How to make them work better. The Lancet, 372(9639), 669–684.
   PubMed Web of Science ®Google Scholar
• Heinzerling, K. G., Kral, A. H., Flynn, N. M., Anderson, R., Scott, A., Gilbert, M. L., et al. (2006). Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement. Drug and Alcohol Dependence, 81(2), 167–178.
   PubMed Web of Science ®Google Scholar
• Kheirandish, P., SeyedAlinaghi, S., Jahani, M., Shirzad, H., Ahmadian, M. S., Majidi, A., et al. (2009). Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. Journal of Urban Health, 86(6), 902–908.
   PubMed Web of Science ®Google Scholar
• Lowndes, C. M., Alary, M., Platt, L. (2003). Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation. Sexually Transmitted Diseases, 30(1), 46–8.
   PubMed Web of Science ®Google Scholar
• Loxley, W. M., Phillips, M., Carruthers, S. J., & Bevan, J. S. (1997). The Australian Study of HIV and injecting drug use. Part I: Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities. Drug and Alcohol Review, 16(3), 207–214.
   PubMed Web of Science ®Google Scholar
• Maher, L., Jalaludin, B., Chant, K., & Kaldor, J. (2005). Hepatitis C among intravenous drug users. Epidemiology, 16(3), 423.
   PubMed Web of Science ®Google Scholar
• Marshall, B. D., Wood, E., Shoveller, J. A., Buxton, J. A., Montaner, J. S., & Kerr, T. (2011). Individual, social, and environmental factors associated with initiating methamphetamine injection: Implications for drug use and HIV prevention strategies. Prevention Science, 12(2), 173–180.
   PubMed Web of Science ®Google Scholar
• Miller, C. L., Johnston, C., Spittal, P. M., Li, K., LaLiberté, N., Montaner, J. S., et al. (2002). Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology, 36(3), 737–742.
   PubMed Web of Science ®Google Scholar
• Nazari, S. S. H., Noroozi, M., Soori, H., Noroozi, A., Mehrabi, Y., Hajebi, A., et al. (2016). The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. International Journal of Drug Policy, 27, 127–131.
   PubMed Web of Science ®Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., et al. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378(9791), 571–583.
   PubMed Web of Science ®Google Scholar
• Noroozi, A., Mirzazadeh, A., Hajebi, A., Farhoudian, A., Sharifi, H., Higgs, P., et al. (2016). Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran. Journal of Substance Use, 1–6. doi:10.1080/14659891.2016.119589
   Web of Science ®Google Scholar
• Noroozi, M. M., Nejat, S., Golestan, B., & Majdzadeh, R. (2012). What are differences between non-injecting and injecting drug addicts? International Journal of Preventive Medicine, 3(6), 314–319.
   Google Scholar
• Noroozi, M., Mirzazadeh, A., Noroozi, A., Mehrabi, Y., Hajebi, A., Zamani, S., et al. (2015). Client-level coverage of needle and syringe program and high-risk‎ injection behaviors: A case study of people who inject drugs in‎ Kermanshah, Iran. Addiction and Health, 7(3–4), 1–9.
   Google Scholar
• Nyamathi, A. M., Dixon, E. L., Robbins, W., Smith, C., Wiley, D., Leake, B., et al. (2002). Risk factors for hepatitis C virus infection among homeless adults. Journal of General Internal Medicine, 17(2), 134–143.
   PubMed Web of Science ®Google Scholar
• Rahbar, A. R., Rooholamini, S., & Khoshnood, K. (2004). Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. International Journal of Drug Policy, 15(2), 151–155.
   Google Scholar
• Rahimi-Movaghar, A., Razaghi, E. M., Sahimi-Izadian, E., Amin-Esmaeili, M. (2010). HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. International Journal of Infectious Diseases, 14(1), e28–e33.
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Armenta, R. A., Wagner, K. D., Roesch, S. C., Bluthenthal, R. N., Cuevas-Mota, J., et al. (2015). Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: A latent class analysis. Substance Use & Misuse, 50(2), 205–214.
   PubMed Web of Science ®Google Scholar
• Samuel, M., Doherty, P., Bulterys, M., & Jenison, S. (2001). Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiology and Infection, 127(3), 475–484.
   PubMed Web of Science ®Google Scholar
• Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., et al. (1995). Correlates of hepatitis C virus infections among injection drug users. Medicine, 74(4), 212–220.
   PubMed Web of Science ®Google Scholar
• Thorpe, L. E., Ouellet, L. J., Hershow, R., Bailey, S. L., Williams, I. T., Williamson, J., et al. (2002). Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology, 155(7), 645–653.
   PubMed Web of Science ®Google Scholar
• Todd, C. S., Abed, A. M., Strathdee, S. A., Scott, P. T., Botros, B. A., Safi, N., et al. (2007). HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerging Infectious Diseases Journal, 13(9), 1327–1331.
   PubMed Web of Science ®Google Scholar
• Zamani, S., Ichikawa, S., Nassirimanesh, B., Vazirian, M., Ichikawa, K., Gouya, M. M., et al. (2007). Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. International Journal of Drug Policy, 18(5), 359–363.
   PubMed Web of Science ®Google Scholar